STOCK RESEARCH & ANALYSIS
The Current Market Cap of GLAND PHARMA is ₹60,686.7 Cr. Current Share Price: ₹3,693.7, Updated EOD on : Oct 22,2021.
| Market Cap Change(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.5% |
-4.6% |
NA |
| SENSEX | -1.5% |
3.2% |
52.4% |
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹60,686.7 Cr | -1.5% | -4.6% | NA | FULL ANALYTICS | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹194,958.0 Cr | -2.7% | 5.6% | 69.1% | FULL ANALYTICS | |
| DIVIS LABORATORIES | ₹134,959.0 Cr | -4.8% | -1.2% | 67.8% | FULL ANALYTICS | |
| DR REDDYS LABORATORIES | ₹77,144.1 Cr | -4.9% | -4.4% | -8% | FULL ANALYTICS | |
| CIPLA | ₹72,276.2 Cr | -0.9% | -7.1% | 19.3% | FULL ANALYTICS | |
| PIRAMAL ENTERPRISES | ₹61,809.1 Cr | -8.1% | -2% | 102.9% | FULL ANALYTICS | |
| CADILA HEALTHCARE | ₹51,432.8 Cr | -6% | -10.5% | 20.8% | FULL ANALYTICS | |
| TORRENT PHARMACEUTICALS | ₹50,227.9 Cr | -4.6% | -3.9% | 12.5% | FULL ANALYTICS | |
| ALKEM LABORATORIES | ₹44,792.0 Cr | -3% | -3.7% | 42.9% | FULL ANALYTICS | |
| ABBOTT INDIA | ₹43,033.6 Cr | -5.4% | -5.7% | 32.5% | FULL ANALYTICS | |
| LUPIN | ₹41,720.5 Cr | -1.9% | -2.2% | -8.9% | FULL ANALYTICS | |
| AUROBINDO PHARMA | ₹40,722.7 Cr | -3.2% | -5% | -11.9% | FULL ANALYTICS | |
| BIOCON | ₹38,893.4 Cr | -5.4% | -11.9% | -21.2% | FULL ANALYTICS | |
| IPCA LABORATORIES | ₹28,907.1 Cr | -5.6% | -6.2% | 8.4% | FULL ANALYTICS | |
| LAURUS LABS | ₹28,802.1 Cr | -16.8% | -13.6% | 72.3% | FULL ANALYTICS | |
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹24,819.7 Cr | -0.7% | -2.4% | -3.3% | FULL ANALYTICS | |
| PFIZER | ₹23,592.1 Cr | -6.2% | -10.9% | 4.5% | FULL ANALYTICS | |
| SANOFI INDIA | ₹19,271.2 Cr | 1.5% | 4.2% | -3.6% | FULL ANALYTICS | |
| AJANTA PHARMA | ₹18,635.5 Cr | -2.6% | -1% | 39.9% | FULL ANALYTICS | |
| NATCO PHARMA | ₹15,300.0 Cr | -5.8% | -6.2% | -6.2% | FULL ANALYTICS | |
| ALEMBIC PHARMACEUTICALS | ₹15,088.2 Cr | -5.4% | -5.5% | -19% | FULL ANALYTICS | |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE 100 LARGECAP TMC | -2.4% | 2.8% | 55.6% |
| S&P BSE LARGE MIDCAP | -2.7% | 2.9% | 57.9% |
| S&P BSE 200 | -2.7% | 2.8% | 58.9% |
| S&P BSE 250 LARGEMIDCAP | -2.9% | 2.7% | 59.4% |
| S&P BSE 500 | -3.1% | 2.7% | 61.2% |
| S&P BSE ALLCAP | -3.2% | 2.7% | 62.3% |
| S&P BSE HEALTHCARE | -4.4% | -5% | 27.9% |
| S&P BSE IPO | -4.9% | 0.7% | 96.3% |
| S&P BSE MID CAP | -5.1% | 1.6% | 76.6% |
| S&P BSE MIDSMALLCAP | -5.5% | 1.7% | 85.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 100 | -2.4% | 2.6% | 55.1% |
| NIFTY LARGE MIDCAP 250 | -2.4% | 4.3% | 70.8% |
| NIFTY 200 | -2.8% | 2.8% | 58.7% |
| NIFTY 500 | -3.1% | 2.7% | 60.9% |
| NIFTY NEXT 50 | -5.2% | -1.3% | 58.4% |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure